Frederic Castinetti, MD, PhD

Professor (Assistant)
Aix Marseille University
Marseille, France

Disclosure information not submitted.

Presentation(s):

• SAT-013 - LINC 6 Ad Hoc Analysis of New Osilodrostat Users: Improvements in Quality of Life in Patients with Cushing'S Syndrome

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT

• SAT-013 - LINC 6 Ad Hoc Analysis of New Osilodrostat Users: Improvements in Quality of Life in Patients with Cushing'S Syndrome

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT

• SAT-036 - Osilodrostat Treatment Outcomes Across Various Etiologies and Severities of Cushing'S Syndrome: LINC 7 Secondary Analysis

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT

• ORF28-07 - A Phase II, Open-Label, Dose-Titration Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of the Novel Anti-ACTH Antibody Asedebart in Adults with Cushing's Disease

  Sunday, June 14, 2026
  2:45 PM - 3:00 PM CT

• MON-019 - Impact of CRH Shortage on the Work-Up of ACTH-Dependent Cushing'S Syndrome and Usefulness of Desmopressin-Based Diagnostic Tests: Insights from 54 European Expert Centres

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT